Jamey Kain

Dr. Jamey Kain is Vice President of Genetic Innovation at Machaon Diagnostics. He leads the effort to clinically validate various rapid genetic sequencing services associated with thrombotic disorders. Dr. Kain’s publications include articles in Nature, PNAS and several other scientific journals.

Dr. Kain comes from a diverse academic background. He completed a postdoctoral fellowship where he used machine vision, machine learning and automation to study the roles of nature, nurture and noise in behavior at Harvard University. Dr. Kain holds a PhD in Biochemistry and a MA in Biology from Harvard where he studied the role of proteolysis during bacterial development. As an undergraduate (BA in Molecular and Cellular Biology from the University of California, Berkeley), he had the good fortune to study aging and DNA damage under Prof. Bruce Ames, the inventor of the famous Ames test.